Form 8-K - Current report:
SEC Accession No. 0001193125-25-266842
Filing Date
2025-11-05
Accepted
2025-11-05 16:00:37
Documents
12
Period of Report
2025-11-05
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K cytk-20251105.htm   iXBRL 8-K 41646
2 EX-99.1 cytk-ex99_1.htm EX-99.1 278089
3 GRAPHIC img114956760_0.jpg GRAPHIC 23462
  Complete submission text file 0001193125-25-266842.txt   473608

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT cytk-20251105.xsd EX-101.SCH 23888
14 EXTRACTED XBRL INSTANCE DOCUMENT cytk-20251105_htm.xml XML 4536
Mailing Address 350 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 350 OYSTER POINT BOULEVARD . SOUTH SAN FRANCISCO CA 94080 (650) 624-3000
CYTOKINETICS INC (Filer) CIK: 0001061983 (see all company filings)

EIN.: 943291317 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-50633 | Film No.: 251453702
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)